ESRRG
Estrogen-related receptor gamma
Also known as: ERR-gamma, ERR3_HUMAN, ERRg, NR3B3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62508
- Gene
- ESRRG
- Ensembl
- ENSG00000196482
- Chromosome
- 1
- Canonical length
- 458 aa
- Protein class
- FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the estrogen receptor-related receptor (ESRR) family, which belongs to the nuclear hormone receptor superfamily. All members of the ESRR family share an almost identical DNA binding domain, which is composed of two C4-type zinc finger motifs. The ESRR members are orphan nuclear receptors; they bind to the estrogen response element and steroidogenic factor 1 response element, and activate genes controlled by both response elements in the absence of any ligands. The ESRR family is closely related to the estrogen receptor (ER) family. They share target genes, co-regulators and promoters, and by targeting the same set of genes, the ESRRs seem to interfere with the ER-mediated estrogen response in various ways. It has been reported that the family member encoded by this gene functions as a transcriptional activator of DNA cytosine-5-methyltransferases 1 (Dnmt1) expression by direct binding to its response elements in the DNMT1 promoters, modulates cell proliferation and estrogen signaling in breast cancer, and negatively regulates bone morphogenetic protein 2-induced osteoblast differentiation and bone formation. Multiple alternatively spliced transcript variants have been identified, which mainly differ at the 5' end and some of which encode protein isoforms differing in the N-terminal region. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
458 residues, UniProt reviewed canonical sequence.
>P62508|ESRRG
1 MDSVELCLPE SFSLHYEEEL LCRMSNKDRH IDSSCSSFIK TEPSSPASLT DSVNHHSPGG
61 SSDASGSYSS TMNGHQNGLD SPPLYPSAPI LGGSGPVRKL YDDCSSTIVE DPQTKCEYML
121 NSMPKRLCLV CGDIASGYHY GVASCEACKA FFKRTIQGNI EYSCPATNEC EITKRRRKSC
181 QACRFMKCLK VGMLKEGVRL DRVRGGRQKY KRRIDAENSP YLNPQLVQPA KKPYNKIVSH
241 LLVAEPEKIY AMPDPTVPDS DIKALTTLCD LADRELVVII GWAKHIPGFS TLSLADQMSL
301 LQSAWMEILI LGVVYRSLSF EDELVYADDY IMDEDQSKLA GLLDLNNAIL QLVKKYKSMK
361 LEKEEFVTLK AIALANSDSM HIEDVEAVQK LQDVLHEALQ DYEAGQHMED PRRAGKMLMT
421 LPLLRQTSTK AVQHFYNIKL EGKVPMHKLF LEMLEAKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ESRRG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.41
- Highest tissue expression
- 44 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 44 nTPM
- retina: 34 nTPM
- stomach: 33 nTPM
- kidney: 27 nTPM
- salivary gland: 15 nTPM
- placenta: 10 nTPM
Single-cell type
- distal convoluted tubule cells: 6,181 nCPM
- renal connecting tubule cells: 4,138 nCPM
- loop of henle epithelial cells: 3,812 nCPM
- renal collecting duct intercalated cells: 3,412 nCPM
- bergmann glia: 2,711 nCPM
- parietal cells: 1,372 nCPM
Immune cell
- neutrophil: 0.1 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- pons: 117 nTPM
- medulla oblongata: 65 nTPM
- cerebellum: 48 nTPM
- cerebral cortex: 38 nTPM
- choroid plexus: 29 nTPM
- white matter: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ESRRG.
Disease | GeneticClinVar
5 pathogenic / likely-pathogenic of 56 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Movement disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.07
- gnomAD missense Z
- 2.56
- DepMap mean gene effect
- -0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of cold-induced thermogenesis
- positive regulation of transcription by RNA polymerase II
- regulation of DNA-templated transcription
- regulation of transcription by RNA polymerase II
- retinoic acid receptor signaling pathway
Molecular functions
- AF-2 domain binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity, RNA polymerase II-specific
- estrogen response element binding
- identical protein binding
- nuclear receptor activity
- nuclear steroid receptor activity
- sequence-specific double-stranded DNA binding
- steroid binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nuclear hormone receptor, ligand-binding domain
- Zinc finger, nuclear hormone receptor-type
- Nuclear hormone receptor
- Retinoic acid receptor
- Zinc finger, NHR/GATA-type
- Estrogen receptor/oestrogen-related receptor
- Oestrogen-related receptor
- Nuclear hormone receptor-like domain superfamily
- Nuclear hormone receptor family NR3 subfamily
- Ligand-binding domain of nuclear hormone receptor
- Double treble clef zinc finger, C4 type
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ESRRG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ESRRG as an antibody target. Whether an autoantibody or antibody against ESRRG could matter depends on whether native ESRRG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ESRRG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ESRRG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...